BMO Capital Markets Increases LB Pharmaceuticals (NASDAQ:LBRX) Price Target to $54.00

BMO Capital Markets Increases LB Pharmaceuticals (NASDAQ:LBRX) Price Target to $54.00

BMO Capital Markets boosted their price objective on LB Pharmaceuticals from $46.00 to $54.00 and gave the company an "outperform" rating in a research report on Wednesday.

LB Pharmaceuticals Inc.: Q2 Earnings Snapshot

NEW YORK (AP) — NEW YORK (AP) — LB Pharmaceuticals Inc. (LBRX) on Tuesday reported a loss of $51.6 million in its second quarter. The New York-based company…

LB Pharmaceuticals Inc GAAP EPS of -$1.71 misses by $0.90

LB Pharmaceuticals (LBRX) Q2 GAAP EPS missed estimates; cash totaled $327.8M plus $150M placement.